Maria I. Morgado-Perez
Madrid, MD 28034, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Aptamer-based inhibition of MNK1 reduces pancreatic ductal adenocarcinoma growth by targeting cancer stem cells.
Journal: Journal of biomedical science
Published: September 16, 2025
An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment.
Journal: Pharmaceutics
Published: March 03, 2023
Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer.
Journal: Cancers
Published: October 27, 2022
An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer.
Journal: Molecular therapy. Nucleic acids
Published: May 31, 2022
DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 24, 2021
Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer.
Journal: Oncotarget
Published: May 18, 2017
Inhibition of Influenza Virus Replication by DNA Aptamers Targeting a Cellular Component of Translation Initiation.
Journal: Molecular therapy. Nucleic acids
Published: December 22, 2015
Characterization of MNK1b DNA Aptamers That Inhibit Proliferation in MDA-MB231 Breast Cancer Cells.
Journal: Molecular therapy. Nucleic acids
Published: September 11, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026